Health Care & Life Sciences » Biotechnology | Galectin Therapeutics Inc.

Galectin Therapeutics Inc. | Key People and Executives

Richard E. Uihlein
Chairman
Marc Rubin
Director
Kevin D. Freeman
Vice Chairman
Theodore Daniel Zucconi
Director
Kary Noel Eldred
Independent Director
Stephen Shulman
Independent Director
Joel Lewis
Independent Director
Gilbert Frank Amelio
Independent Director
Gil S. Omenn
Independent Director
Richard E. Uihlein
Chairman
Harold H. Shlevin
Secretary, Chief Executive & Operating Officer
Jack W. Callicutt
Chief Financial & Accounting Officer
Adam E. Allgood
Executive Director-Clinical Development
Eliezer Zomer
Executive VP-Manufacturing & Product Development
Marc Rubin
Director
Kevin D. Freeman
Vice Chairman
James C. Czirr
Director
Theodore Daniel Zucconi
Director
J. Rex Horton
Executive Director-Regulatory Affairs
Kary Noel Eldred
Independent Director
Stephen Shulman
Independent Director
Joel Lewis
Independent Director
Gilbert Frank Amelio
Independent Director
Gil S. Omenn
Independent Director

About Galectin Therapeutics

View Profile
Address
4960 Peachtree Industrial Boulevard
Norcross Georgia 30071
United States
Employees -
Website http://www.galectintherapeutics.com
Updated 07/08/2019
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.